MedPath

Peking University Peoples Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Selinexor, Pomalidomide, and Dexamethasone For Multiple Myeloma With CNS Involvement

Phase 2
Recruiting
Conditions
Multiple Myeloma
Interventions
First Posted Date
2022-07-28
Last Posted Date
2024-01-31
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
21
Registration Number
NCT05478993
Locations
🇨🇳

Peking University People's Hospital, Beijing, Beijing, China

🇨🇳

Qingdao Municipal Hospital, Qingdao, Shandong, China

The Effect of IVA for Preventing Postvitrectomy Hemorrhage in PDR

Not Applicable
Completed
Conditions
Proliferative Diabetic Retinopathy
Interventions
Procedure: IVA injection before vitrectomy
First Posted Date
2022-07-28
Last Posted Date
2022-07-28
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
154
Registration Number
NCT05478967
Locations
🇨🇳

People's Hospital of Peking University, Beijing, Beijing, China

SJOV vs. HFNO for Hypoxia During Procedural Sedation at High Altitudes

Not Applicable
Recruiting
Conditions
Hypoxia
High Altitude
Interventions
Procedure: HFNO
Procedure: SJOV
First Posted Date
2022-07-26
Last Posted Date
2022-10-17
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
72
Registration Number
NCT05474287
Locations
🇨🇳

Tibet autonomous region people's hospital, Lhasa, Tibet, China

The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Phase 2
Conditions
Immune Thrombocytopenia
Interventions
Drug: TAC
First Posted Date
2022-07-22
Last Posted Date
2022-07-22
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
120
Registration Number
NCT05471050
Locations
🇨🇳

Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China

Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis

First Posted Date
2022-07-21
Last Posted Date
2022-07-21
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
100
Registration Number
NCT05467826

Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia

Phase 2
Not yet recruiting
Conditions
Immune Thrombocytopenia
Interventions
First Posted Date
2022-07-15
Last Posted Date
2022-07-15
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
253
Registration Number
NCT05459649
Locations
🇨🇳

Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China

Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia

Phase 2
Recruiting
Conditions
Immune Thrombocytopenia
ITP
Interventions
First Posted Date
2022-07-07
Last Posted Date
2022-09-28
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
35
Registration Number
NCT05446831
Locations
🇨🇳

Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China

Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM

Phase 1
Recruiting
Conditions
Multiple Myeloma
Interventions
First Posted Date
2022-06-30
Last Posted Date
2023-04-14
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
24
Registration Number
NCT05438394
Locations
🇨🇳

Peking University People's Hospital, Beijing, Beijing, China

The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

Phase 3
Recruiting
Conditions
Purpura, Thrombocytopenic, Idiopathic
Interventions
First Posted Date
2022-06-30
Last Posted Date
2023-11-24
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
96
Registration Number
NCT05438875
Locations
🇨🇳

Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China

🇨🇳

Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China

🇨🇳

Department of Hematology, Beijing Hospital, Beijing, China

and more 2 locations

Transauricular Vagus Nerve Stimulation in the Treatment of Chemotherapy-induced Peripheral Neuropathy

Not Applicable
Conditions
Chemotherapy-induced Peripheral Neuropathy
CIPN
Interventions
Device: sham vagus nerve stimulation
Device: Vagus nerve stimulation
First Posted Date
2022-06-28
Last Posted Date
2022-06-28
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
26
Registration Number
NCT05434403
Locations
🇨🇳

People's Hospital of Peking University, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath